8-91102701-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001129890.2(LRRC69):āc.40A>Gā(p.Lys14Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000239 in 1,551,346 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001129890.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LRRC69 | NM_001129890.2 | c.40A>G | p.Lys14Glu | missense_variant | 1/8 | ENST00000448384.3 | NP_001123362.1 | |
LRRC69 | NM_001354470.2 | c.40A>G | p.Lys14Glu | missense_variant | 1/4 | NP_001341399.1 | ||
LRRC69 | NR_148895.2 | n.83A>G | non_coding_transcript_exon_variant | 1/11 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LRRC69 | ENST00000448384.3 | c.40A>G | p.Lys14Glu | missense_variant | 1/8 | 5 | NM_001129890.2 | ENSP00000400803 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000657 AC: 10AN: 152202Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000255 AC: 4AN: 156564Hom.: 0 AF XY: 0.0000121 AC XY: 1AN XY: 82844
GnomAD4 exome AF: 0.0000193 AC: 27AN: 1399144Hom.: 0 Cov.: 30 AF XY: 0.0000188 AC XY: 13AN XY: 690066
GnomAD4 genome AF: 0.0000657 AC: 10AN: 152202Hom.: 0 Cov.: 32 AF XY: 0.0000807 AC XY: 6AN XY: 74364
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 07, 2024 | The c.40A>G (p.K14E) alteration is located in exon 1 (coding exon 1) of the LRRC69 gene. This alteration results from a A to G substitution at nucleotide position 40, causing the lysine (K) at amino acid position 14 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at